NEWMAN MARY 4
4 · Audentes Therapeutics, Inc. · Filed Nov 16, 2018
Insider Transaction Report
Form 4
NEWMAN MARY
SVP, Regulatory Affairs
Transactions
- Award
Common Stock
2018-11-15$19.64/sh+660$12,959→ 660 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and 16b-3(d).